Mayank Mamtani

Stock Analyst at B. Riley Securities

(0.26)
# 1930
Out of 5,270 analysts
169
Total ratings
35.35%
Success rate
8.82%
Average return
46 Stocks
Name Action Price Target Current % Upside Ratings Updated
Arrowhead Pharma
Reiterates: Buy
51 38
17.72 114.45% 7 Feb 14, 2025
Viking Therapeutics
Reiterates: Buy
109 96
25.71 273.4% 2 Feb 7, 2025
Nektar Therapeutics
Initiates Coverage On: Buy
4
0.81 393.83% 1 Jan 8, 2025
Cognition Therapeuti...
Upgrades: Buy
1 2
0.43 248.84% 3 Dec 19, 2024
Madrigal Pharmaceuti...
Maintains: Neutral
194 236
315.1 -25.1% 11 Nov 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
23 26
7.84 231.63% 19 Oct 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
6 6
4.26 40.85% 2 Oct 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
3 1
n/a n/a 4 Oct 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
33
15 120% 1 Sep 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
50 50
25.57 95.54% 1 Aug 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
20 20
5.97 235.01% 9 Aug 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
29 34
34.41 -1.19% 13 Aug 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
18 5
2.29 118.34% 1 Jul 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
122 92
42.92 114.35% 3 Jun 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
29 33
n/a n/a 7 Feb 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
2
0.47 325.53% 5 Jan 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
8 4
2.56 56.25% 3 Dec 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
7 4
n/a n/a 5 Nov 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
4
0.28 1328.57% 1 Oct 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
15 19
n/a n/a 11 Sep 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
38
15.12 151.32% 1 Sep 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
7 3
0.36 733.33% 5 Apr 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
160
2.55 6174.51% 1 Mar 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
2 1
n/a n/a 4 Nov 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
11 5
1.96 155.1% 3 Aug 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
58 44
2.49 1667.07% 4 Aug 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
120 90
1.52 5821.05% 4 Jul 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
4
0.52 669.23% 1 Jun 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
14 7
7.78 -10.03% 3 May 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
600 450
n/a n/a 1 Mar 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
850 500
n/a n/a 1 Mar 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
1
n/a n/a 6 Mar 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 8
n/a n/a 2 Mar 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
23040 15360
n/a n/a 2 Mar 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
9750 4500
1.83 245801.64% 3 Jan 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
500 270
1.18 22781.36% 2 Nov 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
200
n/a n/a 1 May 27, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
138 77
15.72 389.82% 2 Jan 15, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
96
n/a n/a 2 Jul 6, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
1980 1440
1.97 72996.45% 3 May 22, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
8 4
1.5 166.67% 2 Apr 3, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
70 30
n/a n/a 2 Apr 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
47 39
93.7 -58.38% 2 Mar 18, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
22 11
1.61 583.23% 1 Mar 13, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
43 34
3.54 860.45% 1 Mar 13, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
14 20
n/a n/a 1 Dec 10, 2019